This treatment is offered through a recurring subscription that renews automatically based on your selected billing schedule unless canceled before the next renewal date. Return & subscription details →
This medication is compounded by a licensed pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act and is available only with a patient-specific prescription issued by a licensed healthcare provider following a medical evaluation.
Compounded medications, including Tirzepatide, are not reviewed or approved by the FDA for safety, effectiveness, or quality. While emerging research suggests potential benefits for weight management, individual results may vary. Common side effects may include nausea, diarrhea, vomiting, constipation, and abdominal discomfort.
This compounded Tirzepatide formulation is not affiliated with, endorsed by, or intended to replace FDA-approved products manufactured by Eli Lilly. Product packaging may vary from images shown.